Cargando…
Perspectives and Expertise in Establishing a Therapeutic Drug Monitoring Programme for Challenging Childhood Cancer Patient Populations
The utility of Therapeutic Drug Monitoring (TDM) in the setting of childhood cancer is a largely underused tool, despite the common use of cytotoxic chemotherapeutics. While it is encouraging that modern advances in chemotherapy have transformed outcomes for children diagnosed with cancer, this has...
Autores principales: | Barnett, Shelby, Holden, Victoria, Campbell-Hewson, Quentin, Veal, Gareth J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770741/ https://www.ncbi.nlm.nih.gov/pubmed/35071019 http://dx.doi.org/10.3389/fonc.2021.815040 |
Ejemplares similares
-
Pharmacokinetics and Pharmacogenetics of Cyclophosphamide in a Neonate and Infant Childhood Cancer Patient Population
por: Barnett, Shelby, et al.
Publicado: (2021) -
Vincristine dosing, drug exposure and therapeutic drug monitoring in neonate and infant cancer patients
por: Barnett, Shelby, et al.
Publicado: (2022) -
Psychological perspectives on expertise
por: Campitelli, Guillermo, et al.
Publicado: (2015) -
Generation of evidence-based carboplatin dosing guidelines for neonates and infants
por: Barnett, Shelby, et al.
Publicado: (2023) -
The Death of Expertise: The Campaign Against Established Knowledge and Why It Matters
por: Yoo, Heejeong
Publicado: (2018)